Jacobs Levy Equity Management, Inc Kaleido Biosciences, Inc. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.77 - $11.33 $116,357 - $228,480	-20,166 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$5.09 - $11.07 $9,212 - $20,036	-1,810 Reduced 8.24%	20,166 $223,000
Q2 2020 Aug 17, 2020	BUY	$4.62 - $8.01 $101,529 - $176,027	21,976 New	21,976 $163,000
Q1 2020 May 15, 2020	SELL	$3.62 - $9.49 $209,847 - $550,125	-57,969 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.02 - $8.87 $291,004 - $514,185	57,969 New	57,969 $291,000

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.